New study tests monthly day care for advanced cancer patients
NCT ID NCT04604873
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looked at whether monthly visits to a hospital day care that includes palliative care can improve quality of life for adults with advanced cancer. 144 patients with a life expectancy between 2 and 12 months took part. Researchers measured changes in quality of life, fatigue, and emotional well-being over time.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- hospital day care follow-up with integrated palliative care
- What this could lead to
- If successful, this approach could show that regular palliative day care helps people with advanced cancer maintain a better quality of life and supports their caregivers.
- What could go wrong
- This is a completed, relatively small study (144 people) without a control group, so results may not apply broadly. It focuses on symptom ease and quality of life, not on extending survival or curing cancer.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
144 people
The number who actually took part.
- Started
-
Sep 2020
- Finished
-
Jan 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Patient ≥ 18 years old with advanced solid tumor 2. Addressed for the first time to the palliative care team according to current criteria (medico-psycho-social symptoms, progressive risks) 3. With or without anti-cancer treatment 4. With estimated life expectancy of more than 2 months and less than 12 months 5. Able to communicate in French and answer questionnaires 6. Affiliated with a social security system 7. Having signed informed consent, co-signed by the partner if designated by the patient Exclusion Criteria: 1. Patient with primitive brain tumor or malignant hemopathy 2. Severe psychopathological disorders 3. Pregnant patient or childbearing potential without effective method of birth control 4. Unable to be followed at the cancer center until death 5. Patient deprived of liberty or under guardianship -
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cancer, advanced are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Antoine Lacassagne
Nice, 06189, France
-
Centre Paul Strauss
Strasbourg, 67065, France
-
INSTITUT CURIE Saint-Cloud
Saint-Cloud, 92210, France
-
Institut Bergonie
Bordeaux, 33076, France
-
Institut de Cancerologie de L'Ouest
Saint-Herblain, 44805, France
-
Institutcurie Paris
Paris, 75005, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.